Back
NLS Pharmaceutics Vs. Jabil Industry Stock Comparison
Buy
60
NLSP
NLS Pharmaceutics
Last Price:
0.22
Seasonality Move:
0.67%
Sell
50
JBL
Jabil
Last Price:
108.79
Seasonality Move:
7.32%
Buy
60
NLS Pharmaceutics (NLSP)
is a Buy
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $0.22. The Score for NLSP is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- NLSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Jabil (JBL)
is a Sell
Is Jabil a Buy, Sell or Hold?
- The current Jabil [JBL] share price is $108.79. The Score for JBL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- JBL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $0.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
JBL Stock Price Chart
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 58.46 | Buy |
| Chaikin Money Flow: | 8012392 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.12 - 0.2) | Buy |
| Bollinger Bands (100): | (0.1 - 0.34) | Sell |
JBL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.24 | Sell |
| Relative Strength Index (14 RSI): | 37.88 | Sell |
| Chaikin Money Flow: | -1008932 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (112.36 - 120.94) | Sell |
| Bollinger Bands (100): | (115.92 - 139.9) | Sell |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.2 | Buy |
| 20-day SMA: | 0.16 | Buy |
| 50-day SMA: | 0.15 | Buy |
| 200-day SMA: | 0.4 | Sell |
| 8-day EMA: | 0.2 | Buy |
| 20-day EMA: | 0.17 | Buy |
| 50-day EMA: | 0.18 | Buy |
| 200-day EMA: | 0.4 | Sell |
JBL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 113.44 | Sell |
| 20-day SMA: | 116.13 | Sell |
| 50-day SMA: | 117.48 | Sell |
| 200-day SMA: | 126.38 | Sell |
| 8-day EMA: | 112.6 | Sell |
| 20-day EMA: | 115.36 | Sell |
| 50-day EMA: | 119.13 | Sell |
| 200-day EMA: | 120.59 | Sell |
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Jabil Earnings Growth & JBL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, an increase next quarter of $0.34 per share, a decrease this year of $0.08 per share, and an increase next year of $0.81 per share.
NLS Pharmaceutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Jabil Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||